Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03817125
Title Melanoma Checkpoint and Gut Microbiome Alteration With Microbiome Intervention (MCGRAW)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Parker Institute for Cancer Immunotherapy
Indications

skin melanoma

mucosal melanoma

acral lentiginous melanoma

Therapies

Nivolumab + SER-401

Vancomycin

Nivolumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.